IPP Bureau

Alithea Genomics and Revvity expand global access to scalable transcriptomics platforms
Alithea Genomics and Revvity expand global access to scalable transcriptomics platforms

By IPP Bureau - June 16, 2026

Collaboration integrates MERCURIUS DRUG-seq technologies with Revvity’s screening portfolio, enabling scalable transcriptomic profiling for next-generation drug discovery and AI-driven research

Lumos Health opens applications for second cohort of HealthTech and MedTech startups
Lumos Health opens applications for second cohort of HealthTech and MedTech startups

By IPP Bureau - June 16, 2026

Healthcare speed-scaling platform offers clinical validation, regulatory support, mentorship, and investor access to startups working across preventive health, oncology, genomics, diagnostics, and digital health

India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh
India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh

By IPP Bureau - June 16, 2026

From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape

FDA clears Dexcom’s Stelo as first OTC Continuous Glucose Monitor for kids
FDA clears Dexcom’s Stelo as first OTC Continuous Glucose Monitor for kids

By IPP Bureau - June 16, 2026

Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes

Orionis expands Novartis partnership in potential $1.4 billion molecular glue drug feal
Orionis expands Novartis partnership in potential $1.4 billion molecular glue drug feal

By IPP Bureau - June 16, 2026

Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial
Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial

By IPP Bureau - June 16, 2026

The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor

Roche wins FDA approval for first PTEN-loss companion diagnostic in prostate cancer
Roche wins FDA approval for first PTEN-loss companion diagnostic in prostate cancer

By IPP Bureau - June 16, 2026

The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer

OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI
OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI

By IPP Bureau - June 16, 2026

The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months

Siemens Healthineers begins manufacturing of Atellica chemistry reagents in India
Siemens Healthineers begins manufacturing of Atellica chemistry reagents in India

By IPP Bureau - June 16, 2026

Production at Vadodara facility strengthens Make in India initiative, enhances access to diagnostic testing, and supports preventive healthcare across the country

Philips partners with Bajaj to build digitally connected healthcare network in India
Philips partners with Bajaj to build digitally connected healthcare network in India

By IPP Bureau - June 16, 2026

Collaboration to deploy Philips’ IntelliBridge Enterprise platform across Bajaj Integrated Health System network, enabling seamless patient data flow and integrated care delivery.

Yashoda Medicity, GE Healthcare strengthen partnership to expand AI-powered critical care
Yashoda Medicity, GE Healthcare strengthen partnership to expand AI-powered critical care

By IPP Bureau - June 16, 2026

Discussions focus on integrating ECG diagnostics into AI-enabled E-ICU Command Centre and expanding technology-driven healthcare access across underserved regions

Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact
Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact

By IPP Bureau - June 16, 2026

MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies

Cryoviva brings advanced PrepaCyte-CB cord blood processing technology to India
Cryoviva brings advanced PrepaCyte-CB cord blood processing technology to India

By IPP Bureau - June 16, 2026

Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential

Granules India elevates Ananda Babu Doppalapudi as GM and Head Quality for Vizag API Unit
Granules India elevates Ananda Babu Doppalapudi as GM and Head Quality for Vizag API Unit

By IPP Bureau - June 16, 2026

Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility

T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy
T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy

By IPP Bureau - June 15, 2026

Phase 1 study to evaluate Siglec-6-targeted CAR-T therapy in relapsed or refractory AML and CLL patients, marking a major milestone for T-CURX’s scalable non-viral CAR-T platform

Latest Stories

Interviews

Packaging